Skip to content

Docetaxel Trihydrate

Generic Medicine With 22 Brands Available In Bangladesh. Read What It Is For And How It Is Taken, Then Compare The Brands By Strength, Maker And Price.

Generic Guide

About Docetaxel Trihydrate

What This Generic Is For, How It Is Taken, And What To Watch For.

Indications

Stomach carcinoma Docetaxel is a microtubule inhibitor indicated for: Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC Non-small Cell Lung Cancer (NSCLC) ... Read more Docetaxel is a microtubule inhibitor indicated for: Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC Non-small Cell Lung Cancer (NSCLC): single agent for locally advanced or metastatic NSCLC after platinum therapy failure; and with cisplatin for unresectable, locally advanced or metastatic untreated NSCLC Castration-Resistant Prostate Cancer (CRPC): with prednisone in metastatic castration-resistant prostate cancer Gastric Adenocarcinoma (GC): with cisplatin and fluorouracil for untreated, advanced GC, including the gastroesophageal junction Squamous Cell Carcinoma of the Head and Neck (SCCHN): with cisplatin and fluorouracil for induction treatment of locally advanced SCCHN

Dosage And Administration

Administer in a facility equipped to manage possible complications (e.g., anaphylaxis). Administer intravenously (IV) over 1 hr every 3 weeks. PVC equipment is not recommended. Use only a 21 gauge needle to withdraw docetaxel from the vial. BC locally advanced or metastatic: 60 mg/m2 to 100 mg/m2 single agent BC adjuvant: 75 mg/m2 administered 1 hour after doxorubicin 50 mg/m2 and cyclophosphamide 500 mg/m2 every 3 weeks for 6 cycles NSCLC: after platinum therapy failure: 75 mg/m2 single agent NSCLC: chemotherapy-naive: 75 mg/m2 followed by cisplatin 75 mg/m2 HRPC: 75 mg/m2 with 5 mg prednisone twice a day continuously GC: 75 mg/m2 followed by cisplatin 75 mg/m2 (both on day 1 only) followed by fluorouracil 750 mg/m2 per day as a 24-hr IV (days 1-5), starting at end of cisplatin infusion SCCHN: 75 mg/m2 followed by cisplatin 75 mg/m2 IV (day 1), followed by fluorouracil 750 mg/m2 per day as a 24-hr IV (days 1–5), starting at end of cisplatinin fusion; for 4 cycles SCCHN: 75 mg/m2 followed by cisplatin 100 mg/m2 IV (day 1), followed by fluorouracil 1000 mg/m2 per day as a 24-hr IV (days 1–4); for 3 cycles For all patients: Premedicate with oral corticosteroids Adjust dose as needed

Side Effects

The most common adverse reactions across all docetaxel indications are infections, neutropenia, anemia, febrile neutropenia, hypersensitivity, thrombocytopenia, neuropathy, dysgeusia, dyspnea, constipation, anorexia, nail disorders, fluid retention, asthenia, pain, nausea, diarrhea, vomiting, mucositis, alopecia, skin reactions, and myalgia. Incidence varies depending on the indication. Adverse reactions are described according to indication. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

Precautions And Warnings

Docetaxel should be administered under the supervision of a physician experienced in the use of antineoplastic agents There is a higher risk of developing severe adverse reactions including toxic death and fatal gastrointestinal hemorrhage in patients with hepatic impairment Docetaxel therapy should not be given to patients with neutrophil counts of less than 1,500 cells/mm3 Fatal cases of enterocolitis, including ischemic colitis, colitis and neutropenic enterocolitis have been reported Severe hypersensitivity reactions, with a potential fatal outcome, requiringb immediate discontinuation of Docetaxel may occur. Patients should be closely monitored Treatment related acute myeloid leukemia may occur. No studies have been conducted to assess the carcinogenic potential of Docetaxel

Pregnancy And Lactation

Based on findings in animal reproduction studies and its mechanism of action, docetaxel can cause fetal harm when administered to a pregnant woman. There is no information regarding the presence of docetaxel in human milk, or on its effects on milk production or the breastfed child. No lactation studies in animals have been conducted.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Clinical Details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Available Brand Names: 22

Sorted By
IV Infusion

Daxotel 80 mg/vial

Generic: Docetaxel Trihydrate

8500.00Taka / 80 mg vial

View Medicine
IV Infusion

Docefrez 20 mg/vial

Generic: Docetaxel Trihydrate

4000.00Taka / 20 mg vial

View Medicine
IV Infusion

Docefrez 80 mg/vial

Generic: Docetaxel Trihydrate

12644.00Taka / 80 mg vial

View Medicine
IV Infusion

Docetax 20 mg/vial

Generic: Docetaxel Trihydrate

3500.00Taka / 20 mg vial

View Medicine
IV Infusion

Docetax 80 mg/vial

Generic: Docetaxel Trihydrate

11500.00Taka / 80 mg vial

View Medicine
IV Infusion

Docetaxel AqVida 80 mg/vial

Generic: Docetaxel Trihydrate

11000.00Taka / 80 mg vial

View Medicine
IV Infusion

Docetaxel AqVida 20 mg/vial

Generic: Docetaxel Trihydrate

3700.00Taka / 20 mg vial

View Medicine
IV Infusion

Docetaxel Axios 20 mg/vial

Generic: Docetaxel Trihydrate

4400.00Taka / 20 mg vial

View Medicine
IV Infusion

Docetaxel Axios 80 mg/vial

Generic: Docetaxel Trihydrate

11370.00Taka / 80 mg vial

View Medicine
IV Infusion

Docetaxel HEXAL 80 mg/vial

Generic: Docetaxel Trihydrate

14395.34Taka / 80 mg vial

View Medicine
IV Infusion

Docetaxel HEXAL 20 mg/vial

Generic: Docetaxel Trihydrate

4197.66Taka / 20 mg vial

View Medicine
IV Infusion

Docetaxel PhaRes 20 mg/vial

Generic: Docetaxel Trihydrate

4940.00Taka / 20 mg vial

View Medicine
IV Infusion

Docetor 80 mg/vial

Generic: Docetaxel Trihydrate

13900.00Taka / 80 mg vial

View Medicine
IV Infusion

Docetor 20 mg/vial

Generic: Docetaxel Trihydrate

4000.00Taka / 20 mg vial

View Medicine
IV Infusion

Docexan 20 mg/vial

Generic: Docetaxel Trihydrate

3200.00Taka / 20 mg vial

View Medicine
IV Infusion

Docexan 80 mg/vial

Generic: Docetaxel Trihydrate

11000.00Taka / 80 mg vial

View Medicine
IV Infusion

Taxedol 80 mg/vial

Generic: Docetaxel Trihydrate

12600.00Taka / 80 mg vial

View Medicine
IV Infusion

Taxedol 20 mg/vial

Generic: Docetaxel Trihydrate

4000.00Taka / 20 ml vial

View Medicine
IV Infusion

Taxodoc 20 mg/vial

Generic: Docetaxel Trihydrate

3200.00Taka / 20 mg vial

View Medicine
IV Infusion

Taxodoc 80 mg/vial

Generic: Docetaxel Trihydrate

12000.00Taka / 80 mg vial

View Medicine
IV Infusion

Taxotere 80 mg/vial

Generic: Docetaxel Trihydrate

27724.13Taka / 80 mg vial

View Medicine
IV Infusion

Taxotere 20 mg/vial

Generic: Docetaxel Trihydrate

6985.00Taka / 20 mg vial

View Medicine

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250